Management practices in carotid stenting

Area of Science:

• Neurology
• Vascular Surgery
• Interventional Cardiology

Background:

• Carotid endarterectomy is standard for low-risk severe carotid stenosis.
• It is less suitable for high-risk patient groups.
• Carotid stenting offers an alternative for these patients.

Purpose of the Study:

• To evaluate the safety and efficacy of carotid stenting in high-risk patients.
• To assess the role of antiplatelet therapy in mitigating procedural risks.
• To explore the impact of new technologies on carotid artery disease treatment.

Main Methods:

• Review of initial clinical experiences with carotid stenting.
• Analysis of antiplatelet regimens, including clopidogrel, aspirin, and abciximab.
• Consideration of emboli retrieval devices and nitinol stent technology.

Main Results:

• Carotid stenting is a suitable alternative for high-risk patients.
• Combined antiplatelet therapy (clopidogrel + aspirin +/- abciximab) shows a very low risk of procedural stroke and stent thrombosis.
• This regimen does not appear to increase intracranial hemorrhage risk.

Conclusions:

• Potent antiplatelet regimens, emboli prevention devices, and nitinol stents expand endovascular treatment options for carotid disease.
• These advancements enhance the safety and applicability of carotid stenting.
• Interventional therapy is becoming increasingly viable for a broader range of carotid stenosis patients.